Facile microwave-assisted synthesis and antitubercular evaluation of novel aziridine derivatives
作者:Perumal Sarojini、Malaichamy Jeyachandran、Dharmarajan Sriram、Palraj Ranganathan、S Gandhimathi
DOI:10.1016/j.molstruc.2021.130038
日期:2021.6
MTT-MABA assay. All the aziridine derivatives exhibited improved persuasive antitubercular activity against MTB H37Rv in comparison with standard drugs. Among the tested compounds, 2-(naphthalene-1-yloxy) methyl aziridine (5b), 2-(naphthalene-2-yloxy)methylaziridine (5c), 2-(m-tolyloxymethyl)aziridine (5e), 2-(3-(4-methoxyphenyl)-1-phenylalloxy)methylaziridine (12b) and 2-(3-(2-chlorophenyl)-1-phenylall
通过环氧化物的开环反应制备了新型的2-(芳氧基甲基)氮丙啶和2-((3-芳基-1-苯基烯丙基氧基)甲基)氮丙啶衍生物。使用元素分析(EA),FT-IR,13 C NMR和1 H NMR表征合成的衍生物。使用MTT-MABA测定法评估了合成的化合物对结核分枝杆菌H37Rv(MTB H37Rv)菌株的体外抗结核活性。与标准药物相比,所有氮丙啶衍生物均表现出对MTB H37Rv更具说服力的抗结核活性。在测试的化合物中,2-(萘-1-基氧基)甲基氮丙啶(5b),2-(萘-2-基氧基)甲基氮丙啶(5c),2-(间甲苯基氧基甲基)氮丙啶(5e),2-(3-(4-甲氧基苯基)-1-苯基烯氧基)甲基氮丙啶(12b)和2-(3-(2-氯苯基)-1-苯基烯丙氧基)甲基氮丙啶(12c)显示出良好的前景针对MTB H37Rv的活性。具体而言,化合物5B和12b中显示出的三倍的活性(MIC = 0.5微克/毫升)比标准药物乙胺丁醇(MIC